Clinical Laserthermia Systems AB (publ)

OM:CLS B Stock Report

Market Cap: SEK 71.0m

Clinical Laserthermia Systems Management

Management criteria checks 3/4

Clinical Laserthermia Systems' CEO is Dan Mogren, appointed in Dec 2020, has a tenure of 4.08 years. total yearly compensation is SEK2.17M, comprised of 76.3% salary and 23.7% bonuses, including company stock and options. directly owns 0.091% of the company’s shares, worth SEK64.86K. The average tenure of the management team and the board of directors is 3 years and 3.6 years respectively.

Key information

Dan Mogren

Chief executive officer

SEK 2.2m

Total compensation

CEO salary percentage76.3%
CEO tenure4.1yrs
CEO ownership0.09%
Management average tenure3yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Jan 03
We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Aug 26
Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Mar 01
Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

CEO Compensation Analysis

How has Dan Mogren's remuneration changed compared to Clinical Laserthermia Systems's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 64m

Jun 30 2024n/an/a

-SEK 68m

Mar 31 2024n/an/a

-SEK 71m

Dec 31 2023SEK 2mSEK 2m

-SEK 80m

Sep 30 2023n/an/a

-SEK 63m

Jun 30 2023n/an/a

-SEK 77m

Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022SEK 1mSEK 1m

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensation vs Market: Dan's total compensation ($USD195.14K) is about average for companies of similar size in the Swedish market ($USD230.87K).

Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.

CEO

Dan Mogren (60 yo)

4.1yrs

Tenure

SEK 2,174,979

Compensation

Mr. Dan Johansson Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief...

Leadership Team

NamePositionTenureCompensationOwnership
Dan Mogren
Chief Executive Officer4.1yrsSEK 2.17m0.091%
SEK 64.9k
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 125.00kno data
Hakan Rosqvist
Interim Chief Financial Officerless than a yearno datano data
Jimmy Johansson
Executive Vice President of Operations1.7yrsno data0.00097%
SEK 688.6
Cristina Pantaleone
Chief Technical Officer3yrsno datano data
Liselotte Nilsson
Vice President of Marketing4yrsno data0.0032%
SEK 2.3k

3.0yrs

Average Tenure

56yo

Average Age

Experienced Management: CLS B's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lars-Erik Eriksson
Co-Founder & Director19yrsSEK 125.00kno data
Stephan Dymling
Member of Clinical Advisory Boardno dataSEK 125.00k0.0054%
SEK 3.8k
Rolf Kiessling
Member of Clinical Advisory Board3.6yrsSEK 80.00kno data
Karl-Göran Tranberg
Member of Clinical Advisory Board3.6yrsSEK 80.00kno data
Marika Crohns
Independent Director & Member of Clinical Advisory Board5yrsSEK 125.00k0.0048%
SEK 3.4k
Sandy Brandmeier
Independent Director4yrsSEK 125.00k0.0089%
SEK 6.3k
Peter Mantas
Independent Directorless than a yearno datano data
Peter Max
Independent Chairman of the Boardless than a yearno datano data

3.6yrs

Average Tenure

72yo

Average Age

Experienced Board: CLS B's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:02
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clinical Laserthermia Systems AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hans MählerNordea Markets
Erik NordströmRedeye
Gustaf MeyerRedeye